Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1457) 1457
science & technology (1414) 1414
life sciences & biomedicine (1338) 1338
ribavirin (1050) 1050
ribavirin - therapeutic use (992) 992
antiviral agents - therapeutic use (964) 964
male (940) 940
hepatitis c (929) 929
female (904) 904
hepatitis c, chronic - drug therapy (884) 884
middle aged (759) 759
drug therapy, combination (755) 755
adult (720) 720
interferon-alpha - therapeutic use (709) 709
interferon (688) 688
treatment outcome (590) 590
gastroenterology & hepatology (583) 583
hepatitis c virus (581) 581
infectious diseases (545) 545
ribavirin - administration & dosage (486) 486
recombinant proteins (460) 460
hepatitis (453) 453
hepacivirus - genetics (451) 451
biological and medical sciences (444) 444
medical sciences (439) 439
polyethylene glycols - therapeutic use (436) 436
genotype (417) 417
antiviral agents - administration & dosage (416) 416
antiviral agents - adverse effects (385) 385
health aspects (374) 374
antiviral agents (356) 356
biological response modifiers (352) 352
ribavirin - adverse effects (350) 350
drug therapy (335) 335
interferon-alpha - administration & dosage (333) 333
hepatitis c - drug therapy (324) 324
interferon-alpha - adverse effects (322) 322
aged (317) 317
viral diseases (308) 308
hepatitis c, chronic - virology (305) 305
care and treatment (297) 297
human viral diseases (282) 282
hepacivirus - drug effects (258) 258
virology (258) 258
viral hepatitis (256) 256
pharmacology. drug treatments (238) 238
recombinant proteins - therapeutic use (233) 233
viral load (229) 229
infections (228) 228
pharmacology & pharmacy (203) 203
virus diseases (199) 199
animals (195) 195
rna, viral - blood (191) 191
polyethylene glycols - administration & dosage (187) 187
analysis (184) 184
hepatitis c, chronic - complications (183) 183
viruses (183) 183
polyethylene glycols - adverse effects (181) 181
genetic aspects (174) 174
antibiotics. antiinfectious agents. antiparasitic agents (169) 169
research (163) 163
abridged index medicus (162) 162
risk factors (157) 157
gastroenterology and hepatology (155) 155
liver (153) 153
genotype & phenotype (152) 152
genotypes (149) 149
prospective studies (147) 147
young adult (147) 147
patients (144) 144
chronic hepatitis c (142) 142
time factors (139) 139
adolescent (137) 137
interferons - therapeutic use (136) 136
hcv (129) 129
hepatology (125) 125
retrospective studies (125) 125
gastroenterology. liver. pancreas. abdomen (124) 124
hiv infections - complications (124) 124
medicine & public health (124) 124
pegylated interferon (123) 123
ribavirin - pharmacology (123) 123
hepacivirus - isolation & purification (122) 122
antiviral agents - pharmacology (121) 121
liver diseases (120) 120
microbiology (119) 119
general & internal medicine (118) 118
drug administration schedule (117) 117
hiv (115) 115
medicine, general & internal (115) 115
dosage and administration (114) 114
dose-response relationship, drug (113) 113
hepatitis c - complications (113) 113
hepatitis c, chronic - genetics (113) 113
liver cirrhosis (113) 113
cirrhosis (111) 111
immunology (109) 109
digestive system diseases (107) 107
medicine (107) 107
research article (107) 107
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1934) 1934
Chinese (13) 13
Russian (13) 13
French (9) 9
Portuguese (8) 8
Spanish (8) 8
German (7) 7
Japanese (6) 6
Korean (4) 4
Croatian (3) 3
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Polish (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cost‐effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
by Martin, Natasha K and Vickerman, Peter and Miners, Alec and Foster, Graham R and Hutchinson, Sharon J and Goldberg, David J and Hickman, Matthew
Hepatology (Baltimore, Md.), ISSN 0270-9139, 01/2012, Volume 55, Issue 1, pp. 49 - 57
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Antiviral agents | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Adult and adolescent clinical studies | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Addictive behaviors | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Injections, Intravenous | Prevalence | Antiviral Agents - therapeutic use | Ribavirin - economics | Humans | Ribavirin - therapeutic use | Risk Factors | Interferon-alpha - therapeutic use | Interferon-alpha - economics | Secondary Prevention | Cost-Benefit Analysis - statistics & numerical data | Polyethylene Glycols - economics | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - economics | Polyethylene Glycols - therapeutic use | Syringes | Drug Costs - statistics & numerical data | Substance-Related Disorders - epidemiology | Needles | Substance-Related Disorders - economics | Antiviral Agents - economics | Hepatitis C, Chronic - epidemiology | United Kingdom - epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
by Margaret Hellard and Rachel Sacks-Davis and Judy Gold
Clinical infectious diseases, ISSN 1058-4838, 8/2009, Volume 49, Issue 4, pp. 561 - 573
Injections | Health outcomes | Review Articles | Interferons | Chronic hepatitis | Antivirals | Treatment compliance | Experimentation | Infections | Hepatitis C | Hepacivirus | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Viral diseases | Biological and medical sciences | Medical sciences | Drug addictions | Toxicology | Viral hepatitis | Infectious diseases | Psychopathology. Psychiatry | Addictive behaviors | Human viral diseases | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Ribavirin - therapeutic use | Treatment Outcome | Interferons - therapeutic use | Substance Abuse, Intravenous - complications | Drug Users | Drug abuse | Care and treatment | Research | Demographic aspects | Hepatitis | Interferon | Comparative analysis | Medical treatment | Drug use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Risk factors associated with the severity of adverse drug reactions by Xiyanping injection: A propensity score-matched analysis
by Zheng, Rui and Tao, Liyuan and Kwong, Joey S.W and Zhong, Changming and Li, Chengyu and Chen, Shiqi and Sun, Yang and Zhang, Xiaoyu and Shang, Hongcai
Journal of ethnopharmacology, ISSN 0378-8741, 03/2020, Volume 250, pp. 112424 - 112424
Herb-drug interaction | Traditional Chinese medicine injection | Risk factor | Propensity score matching | Adverse drug reaction | Xiyanping injection | Ribavirin | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Integrative & Complementary Medicine | Plant Sciences | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Treatment of hepatitis C infection in injection drug users
by Backmund, Markus and Meyer, Kirsten and Von Zielonka, Michael and Eichenlaub, Dieter
Hepatology (Baltimore, Md.), ISSN 0270-9139, 07/2001, Volume 34, Issue 1, pp. 188 - 193
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Drug addictions | Biological and medical sciences | Toxicology | Medical sciences | Recurrence | Prospective Studies | Hepatitis C - drug therapy | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Treatment Outcome | Alanine Transaminase - blood | Recombinant Proteins | Sex Characteristics | Substance Abuse, Intravenous | Interferon-alpha - administration & dosage | Ribavirin - adverse effects | Ribavirin - administration & dosage | Polymerase Chain Reaction | Opioid-Related Disorders | Adult | Female | Interferon-alpha - adverse effects | Patient Compliance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Qingkailing Injection () for Treatment of Children Pneumonia Induced by Respiratory Syncytial Virus: A Meta-Analysis of Randomized Controlled Trials
by He, Shuai and Li, Wen-shi and Luo, Ya-jun and Ye, Chen-li and Zhang, Zhong-yi
Chinese journal of integrative medicine, ISSN 1672-0415, 04/2018, Volume 24, Issue 4, pp. 288 - 295
Chinese medicine | ribavirin | pneumonia | children | meta-analysis | Qingkailing Injection | randomized controlled trials | respiratory tract infection | respiratory syncytial virus | Life Sciences & Biomedicine | Integrative & Complementary Medicine | Science & Technology
Journal Article
Details down arrow
6. Full Text Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users
by Grebely, Jason and Raffa, Jesse D and Meagher, Caite and Duncan, Fiona and Genoway, Krista A and Khara, Milan and McLean, Mark and Mead, Annabel and Viljoen, Mark and DeVlaming, Stanley and Fraser, Chris and Conway, Brian
Journal of gastroenterology and hepatology, ISSN 0815-9319, 09/2007, Volume 22, Issue 9, pp. 1519 - 1525
injection drug users | pegylated interferon | ribavirin | illicit drug users | interferon | Interferon | Illicit drug users | Pegylated interferon | Ribavirin | Injection drug users | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Viral diseases | Biological and medical sciences | Medical sciences | Drug addictions | Toxicology | Viral hepatitis | Infectious diseases | Psychopathology. Psychiatry | Addictive behaviors | Human viral diseases | Hepatitis C - drug therapy | Polyethylene Glycols | Antiviral Agents - therapeutic use | Humans | Interferon-alpha - therapeutic use | Hepacivirus - genetics | Genotype | Male | Alanine Transaminase - blood | British Columbia | Biomarkers - blood | Recombinant Proteins | Substance Abuse, Intravenous - rehabilitation | Adult | Female | Hepatitis C - transmission | Hepatitis C | Drug therapy | Biological response modifiers | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Combination therapy of natural human interferon‐beta and ribavirin for chronic hepatitis C patients with injection drug use
by Morikawa, Hiroyasu and Kozuka, Ritsuzo and Fujii, Hideki and Iwai, Shuji and Enomoto, Masaru and Tamori, Akihiro and Saito, Shinobu and Kawada, Norifumi
Hepatology research, ISSN 1386-6346, 10/2013, Volume 43, Issue 10, pp. 1013 - 1019
injection drug user | ribavirin | natural interferon‐β | chronic hepatitis C | Natural interferon-β | Chronic hepatitis C | Injection drug user | Ribavirin | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Analysis | Depression, Mental | Hemoglobin | Interferon | Biological response modifiers | Hepatitis C | Drug therapy | Depression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Comparative Efficacy of Chinese Herbal Injections for the Treatment of Herpangina: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by Duan, Xiaojiao and Wang, Haojia and Wu, Jiarui and Zhou, Wei and Wang, Kaihuan and Liu, Xinkui
Frontiers in pharmacology, ISSN 1663-9812, 05/2020, Volume 11, pp. 693 - 693
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | ribavirin | Chinese herbal injections | network meta-analysis | Bayesian model | herpangina
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text HCV antiviral therapy in injection drug users: difficult to treat or easy to cure?
by Persico, Marcello and Coppola, Nicola and Rosato, Valerio and Abenavoli, Ludovico and Masarone, Mario and Luna, Antonio De
Annals of hepatology, ISSN 1665-2681, 2015, Volume 14, Issue 3, pp. 325 - 332
Gastroenterology and Hepatology | Sustained virological response | Chronic hepatitis C | Antiviral treatment | Injection drug users | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Follow-Up Studies | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Drug Users | Polyethylene Glycols - therapeutic use | Drug Carriers | Young Adult | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Hepatitis C virus relapse was suppressed by long‐term self‐injection of low‐dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment
by Takashima, Tomoyuki and Enomoto, Hirayuki and Ninomiya, Toshiaki and Kim, Soo Ryang and Okushin, Hiroaki and Sugano, Masahiko and Imoto, Susumu and Yano, Yoshihiko and Ooka, Teruji and Seo, Yasushi and Kasugai, Hiroshi and Muramatsu, Akira and Jomura, Hisato and Shimomura, Soji and Shindo, Michiko and Nakamura, Hideji and Aizawa, Nobuhiro and Iwata, Yoshinori and Saito, Masaki and Imanishi, Hiroyasu and Iijma, Hiroko and Nishiguchi, Shuhei
Hepatology research, ISSN 1386-6346, 06/2014, Volume 44, Issue 6, pp. 597 - 607
hepatitis C virus | pegylated interferon | interferon‐α | chronic hepatitis C | Chronic hepatitis C | Interferon-α | Hepatitis C virus | Pegylated interferon | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Relapse | Care and treatment | Dosage and administration | Interferon | Biological response modifiers | Ribavirin | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype
by Han, Hwalih and Noureddin, Mazen and Witthaus, Michael and Park, Yoon J and Hoofnagle, Jay H and Liang, T. Jake and Rotman, Yaron
Journal of hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 5, pp. 957 - 963
Gastroenterology and Hepatology | IL28B | Temperature | Treatment | Hepatitis C | Interferon alfa | Fever | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Prospective Studies | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Body Temperature - physiology | Polyethylene Glycols - therapeutic use | Fever - physiopathology | Interleukins - genetics | Adult | Female | Retrospective Studies | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Body Temperature - genetics | Fever - genetics | Polymorphism, Single Nucleotide - genetics | Care and treatment | Genetic aspects | Interferon | Biological response modifiers | Viral antigens | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights